Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 2/2015

01.03.2015 | Original Article

Successive distinct high-grade gliomas in L-2-hydroxyglutaric aciduria

verfasst von: Zoltan Patay, Brent A. Orr, Barry L. Shulkin, Scott N. Hwang, Yuan Ying, Alberto Broniscer, Frederick A. Boop, David W. Ellison

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Patients with L-2-hydroxyglutaric aciduria are at risk for developing cerebral neoplasms, particularly gliomas, as one of the optical isomers of the known oncometabolite, 2-hydroxyglutarate is produced in L-2-hydroxyglutaric aciduria. To illustrate the concept of sustained oncogenic potential in permanent exposure to L-2-hydroxyglutarate in brain tissue, we present the medical history of a patient with L-2-hydroxyglutaric aciduria who underwent surgery to remove a right temporal anaplastic astrocytoma and developed an anatomically distinct, but histopathologically similar, tumor in the left frontal region 40 months later. This is the first reported case of successive distinct gliomas in a patient with L-2-hydroxyglutaric aciduria. While this implies a significant, cumulative lifetime risk for cerebral neoplasms in patients with this rare organic aciduria, it also allows further insight into a unique mechanism of tumorigenesis in the brain.
Literatur
Zurück zum Zitat Barth PG, Hoffmann GF, Jaeken J et al (1992) L-2-hydroxyglutaric acidemia: a novel inherited neurometabolic disease. Ann Neurol 32(1):66–71CrossRefPubMed Barth PG, Hoffmann GF, Jaeken J et al (1992) L-2-hydroxyglutaric acidemia: a novel inherited neurometabolic disease. Ann Neurol 32(1):66–71CrossRefPubMed
Zurück zum Zitat Cerami E, Gao J, Dogrusoz U et al (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2(5):401–404 [Erratum appears in Cancer Discov. 2012 Oct;2(10):960]CrossRefPubMed Cerami E, Gao J, Dogrusoz U et al (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2(5):401–404 [Erratum appears in Cancer Discov. 2012 Oct;2(10):960]CrossRefPubMed
Zurück zum Zitat da Silva CG, Bueno ARF, Schuck PF et al (2004) Inhibition of creatine kinase activity from rat cerebral cortex by D-2-hydroxyglutaric acid in vitro. Neurochem Int 44(1):45–52CrossRefPubMed da Silva CG, Bueno ARF, Schuck PF et al (2004) Inhibition of creatine kinase activity from rat cerebral cortex by D-2-hydroxyglutaric acid in vitro. Neurochem Int 44(1):45–52CrossRefPubMed
Zurück zum Zitat D'Incerti L, Farina L, Moroni I, Uziel G, Savoiardo M (1998) L-2-Hydroxyglutaric aciduria: MRI in seven cases. Neuroradiology 40(11):727–733 D'Incerti L, Farina L, Moroni I, Uziel G, Savoiardo M (1998) L-2-Hydroxyglutaric aciduria: MRI in seven cases. Neuroradiology 40(11):727–733
Zurück zum Zitat Duran M, Kamerling JP, Bakker HD, van Gennip AH, Wadman SK (1980) L-2-hydroxyglutaric aciduria: an inborn error of metabolism? J Inherit Metab Dis 3(4):109–112CrossRefPubMed Duran M, Kamerling JP, Bakker HD, van Gennip AH, Wadman SK (1980) L-2-hydroxyglutaric aciduria: an inborn error of metabolism? J Inherit Metab Dis 3(4):109–112CrossRefPubMed
Zurück zum Zitat Hartmann C, Meyer J, Balss J et al (2009) Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1010 diffuse gliomas. Acta Neuropathol (Berl) 118(4):469–474CrossRef Hartmann C, Meyer J, Balss J et al (2009) Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1010 diffuse gliomas. Acta Neuropathol (Berl) 118(4):469–474CrossRef
Zurück zum Zitat Koivunen P, Lee S, Duncan CG et al (2012) Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature 483(7390):484–488CrossRefPubMedCentralPubMed Koivunen P, Lee S, Duncan CG et al (2012) Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature 483(7390):484–488CrossRefPubMedCentralPubMed
Zurück zum Zitat Koprivica V, Cho K-S, Park JB et al (2005) EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans. Science 310(5745):106–110CrossRefPubMed Koprivica V, Cho K-S, Park JB et al (2005) EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans. Science 310(5745):106–110CrossRefPubMed
Zurück zum Zitat Kranendijk M, Struys EA, Salomons GS, Van der Knaap MS, Jakobs C (2012) Progress in understanding 2-hydroxyglutaric acidurias. J Inherit Metab Dis 35(4):571–587CrossRefPubMedCentralPubMed Kranendijk M, Struys EA, Salomons GS, Van der Knaap MS, Jakobs C (2012) Progress in understanding 2-hydroxyglutaric acidurias. J Inherit Metab Dis 35(4):571–587CrossRefPubMedCentralPubMed
Zurück zum Zitat Latini A, Scussiato K, Rosa RB et al (2003) Induction of oxidative stress by L-2-hydroxyglutaric acid in rat brain. J Neurosci Res 74(1):103–110CrossRefPubMed Latini A, Scussiato K, Rosa RB et al (2003) Induction of oxidative stress by L-2-hydroxyglutaric acid in rat brain. J Neurosci Res 74(1):103–110CrossRefPubMed
Zurück zum Zitat Lu C, Ward PS, Kapoor GS et al (2012) IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 483(7390):474–478CrossRefPubMedCentralPubMed Lu C, Ward PS, Kapoor GS et al (2012) IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 483(7390):474–478CrossRefPubMedCentralPubMed
Zurück zum Zitat Moroni I, Bugiani M, D'Incerti L et al (2004) L-2-hydroxyglutaric aciduria and brain malignant tumors: a predisposing condition? Neurology 62(10):1882–1884CrossRefPubMed Moroni I, Bugiani M, D'Incerti L et al (2004) L-2-hydroxyglutaric aciduria and brain malignant tumors: a predisposing condition? Neurology 62(10):1882–1884CrossRefPubMed
Zurück zum Zitat Patay Z, Mills JC, Lobel U, Lambert A, Sablauer A, Ellison DW (2012) Cerebral neoplasms in L-2 hydroxyglutaric aciduria: 3 new cases and meta-analysis of literature data. AJNR Am J Neuroradiol 33(5):940–943CrossRefPubMed Patay Z, Mills JC, Lobel U, Lambert A, Sablauer A, Ellison DW (2012) Cerebral neoplasms in L-2 hydroxyglutaric aciduria: 3 new cases and meta-analysis of literature data. AJNR Am J Neuroradiol 33(5):940–943CrossRefPubMed
Zurück zum Zitat Rzem R, Veiga-da-Cunha M, Noel G et al (2004) A gene encoding a putative FAD-dependent L-2-hydroxyglutarate dehydrogenase is mutated in L-2-hydroxyglutaric aciduria. Proc Natl Acad Sci U S A 101(48):16849–16854CrossRefPubMedCentralPubMed Rzem R, Veiga-da-Cunha M, Noel G et al (2004) A gene encoding a putative FAD-dependent L-2-hydroxyglutarate dehydrogenase is mutated in L-2-hydroxyglutaric aciduria. Proc Natl Acad Sci U S A 101(48):16849–16854CrossRefPubMedCentralPubMed
Zurück zum Zitat Steenweg ME, Salomons GS, Yapici Z et al (2009) L-2-hydroxyglutaric aciduria: pattern of MR imaging abnormalities in 56 patients. Radiology 251(3):856–865 Steenweg ME, Salomons GS, Yapici Z et al (2009) L-2-hydroxyglutaric aciduria: pattern of MR imaging abnormalities in 56 patients. Radiology 251(3):856–865
Zurück zum Zitat Topcu M, Jobard F, Halliez S et al (2004) L-2-hydroxyglutaric aciduria: identification of a mutant gene C14orf160, localized on chromosome 14q22.1. Hum Mol Genet 13(22):2803–2811 Topcu M, Jobard F, Halliez S et al (2004) L-2-hydroxyglutaric aciduria: identification of a mutant gene C14orf160, localized on chromosome 14q22.1. Hum Mol Genet 13(22):2803–2811
Zurück zum Zitat Topcu M, Aydin OF, Yalcinkaya C et al (2005) L-2-hydroxyglutaric aciduria: a report of 29 patients. Turk J Pediatr 47(1):1–7PubMed Topcu M, Aydin OF, Yalcinkaya C et al (2005) L-2-hydroxyglutaric aciduria: a report of 29 patients. Turk J Pediatr 47(1):1–7PubMed
Metadaten
Titel
Successive distinct high-grade gliomas in L-2-hydroxyglutaric aciduria
verfasst von
Zoltan Patay
Brent A. Orr
Barry L. Shulkin
Scott N. Hwang
Yuan Ying
Alberto Broniscer
Frederick A. Boop
David W. Ellison
Publikationsdatum
01.03.2015
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 2/2015
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-014-9782-8

Weitere Artikel der Ausgabe 2/2015

Journal of Inherited Metabolic Disease 2/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.